Sherbrooke Park Advisers LLC Increases Stake in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Sherbrooke Park Advisers LLC raised its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 229.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 34,019 shares of the company’s stock after acquiring an additional 23,683 shares during the quarter. Sherbrooke Park Advisers LLC’s holdings in Aveanna Healthcare were worth $155,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. KLP Kapitalforvaltning AS bought a new position in Aveanna Healthcare in the 4th quarter valued at $35,000. BNP Paribas Financial Markets bought a new position in Aveanna Healthcare in the 4th quarter valued at $35,000. Tower Research Capital LLC TRC grew its position in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock valued at $36,000 after acquiring an additional 6,854 shares during the last quarter. Catalyst Funds Management Pty Ltd grew its position in Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after acquiring an additional 9,000 shares during the last quarter. Finally, Sagespring Wealth Partners LLC bought a new position in Aveanna Healthcare in the 4th quarter valued at $57,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $5.49 on Thursday. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of -16.15 and a beta of 2.01. The stock has a 50 day moving average price of $5.10 and a 200 day moving average price of $4.94. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.32 and a 52-week high of $6.19.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AVAH. UBS Group boosted their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a report on Friday, May 9th. Truist Financial lowered their price target on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a report on Friday, April 11th.

Insider Buying and Selling at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $5.51, for a total value of $339,217.64. Following the completion of the sale, the insider now owns 1,453,948 shares of the company’s stock, valued at $8,011,253.48. This trade represents a 4.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the firm’s stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total value of $531,796.24. Following the completion of the sale, the insider now directly owns 545,330 shares of the company’s stock, valued at $3,184,727.20. The trade was a 14.31% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,887,612 shares of company stock worth $26,269,057 over the last quarter. Insiders own 7.80% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.